OncoZenge AB (publ) (ONCOZ.ST)
SEK 5.11
(2.0%)
SEK 5.11
(2.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 7.26 Million SEK | 135.62% |
| 2022 | -43.56 Million SEK | -316.86% |
| 2021 | -4.89 Million SEK | -510.99% |
| 2020 | -801 Thousand SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.37 Million SEK | 100.0% |
| 2024 Q2 | -2.04 Million SEK | 0.0% |
| 2023 Q1 | -4.05 Million SEK | 11.02% |
| 2023 FY | - SEK | 22.05% |
| 2023 Q3 | -4.18 Million SEK | 6.79% |
| 2023 Q2 | -4.49 Million SEK | -10.83% |
| 2023 Q4 | -3.17 Million SEK | 24.29% |
| 2022 Q4 | -4.55 Million SEK | -42.03% |
| 2022 FY | - SEK | -316.86% |
| 2022 Q3 | -3.2 Million SEK | -13.64% |
| 2022 Q2 | -2.82 Million SEK | 71.25% |
| 2022 Q1 | -9.81 Million SEK | -614.48% |
| 2021 Q3 | -987 Thousand SEK | 10.92% |
| 2021 Q2 | -1.1 Million SEK | 22.25% |
| 2021 Q1 | -1.42 Million SEK | 0.0% |
| 2021 Q4 | -1.37 Million SEK | -39.21% |
| 2021 FY | - SEK | -510.99% |
| 2020 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Calliditas Therapeutics AB (publ) | -367.8 Million SEK | 101.976% |
| AcouSort AB (publ) | -16.7 Million SEK | 143.501% |
| Active Biotech AB (publ) | -43.88 Million SEK | 116.556% |
| Alzinova AB (publ) | 41.99 Thousand SEK | -17200.412% |
| Amniotics AB (publ) | -27.14 Million SEK | 126.769% |
| Asarina Pharma AB (publ) | -14.21 Million SEK | 151.108% |
| BioArctic AB (publ) | 275.38 Million SEK | 97.362% |
| Camurus AB (publ) | 562.54 Million SEK | 98.708% |
| Cantargia AB (publ) | -284.31 Million SEK | 102.556% |
| Scandinavian ChemoTech AB (publ) | -19.57 Million SEK | 137.111% |
| Elicera Therapeutics AB (publ) | -17.08 Million SEK | 142.53% |
| Genovis AB (publ.) | 64.57 Million SEK | 88.747% |
| Guard Therapeutics International AB (publ) | -114.9 Million SEK | 106.323% |
| Mendus AB (publ) | -97.84 Million SEK | 107.426% |
| Kancera AB (publ) | -61.88 Million SEK | 111.74% |
| Karolinska Development AB (publ) | -26.78 Million SEK | 127.129% |
| LIDDS AB (publ) | -39.67 Million SEK | 118.316% |
| Lipum AB (publ) | -37.11 Million SEK | 119.575% |
| Lipigon Pharmaceuticals AB (publ) | -12.1 Million SEK | 160.03% |
| Magle Chemoswed Holding AB (publ) | 31.4 Million SEK | 76.863% |
| Modus Therapeutics Holding AB (publ) | 2000.00 SEK | -363200.0% |
| NextCell Pharma AB | -40.98 Million SEK | 117.728% |
| Saniona AB (publ) | -69.69 Million SEK | 110.425% |
| Simris Alg AB (publ) | -22.36 Million SEK | 132.491% |
| Vicore Pharma Holding AB (publ) | -317.46 Million SEK | 102.289% |
| Xbrane Biopharma AB (publ) | -282.03 Million SEK | 102.576% |
| Xintela AB (publ) | -53.47 Million SEK | 113.589% |
| Ziccum AB (publ) | -20.34 Million SEK | 135.719% |
| Isofol Medical AB (publ) | -37.02 Million SEK | 119.625% |
| Xspray Pharma AB (publ) | -169.81 Million SEK | 104.279% |
| CombiGene AB (publ) | -35.33 Million SEK | 120.563% |
| Diamyd Medical AB (publ) | -140.85 Million SEK | 105.159% |
| Intervacc AB (publ) | -68.98 Million SEK | 110.533% |
| Alligator Bioscience AB (publ) | -237.61 Million SEK | 103.058% |
| Sprint Bioscience AB (publ) | -2.08 Million SEK | 449.327% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | -13.43 Million SEK | 154.099% |
| Corline Biomedical AB | -1.69 Million SEK | 529.687% |
| IRLAB Therapeutics AB (publ) | -173.32 Million SEK | 104.192% |
| Bio-Works Technologies AB (publ) | -54.8 Million SEK | 113.258% |
| Aptahem AB (publ) | -10 Million SEK | 172.593% |
| Infant Bacterial Therapeutics AB (publ) | 11.54 Million SEK | 37.085% |
| Fluicell AB (publ) | -25.91 Million SEK | 128.039% |
| Biovica International AB (publ) | -119.5 Million SEK | 106.08% |
| Spago Nanomedical AB (publ) | -42.22 Million SEK | 117.208% |
| Abliva AB (publ) | -93.6 Million SEK | 107.762% |
| Egetis Therapeutics AB (publ) | -319.1 Million SEK | 102.277% |
| 2cureX AB (publ) | -35.13 Million SEK | 120.68% |
| I-Tech AB | 30.34 Million SEK | 76.055% |
| Hansa Biopharma AB (publ) | -714.55 Million SEK | 101.017% |
| Cyxone AB (publ) | -20.41 Million SEK | 135.593% |
| ExpreS2ion Biotech Holding AB (publ) | -102.45 Million SEK | 107.092% |
| Biosergen AB | 228 Thousand SEK | -3086.842% |
| Nanologica AB (publ) | -62.11 Million SEK | 111.697% |
| SynAct Pharma AB | -222.7 Million SEK | 103.263% |
| Annexin Pharmaceuticals AB (publ) | -43.86 Million SEK | 116.566% |
| BioInvent International AB (publ) | -312.7 Million SEK | 102.324% |
| Stayble Therapeutics AB (publ) | 309.41 Thousand SEK | -2248.318% |
| Oncopeptides AB (publ) | -231.62 Million SEK | 103.137% |
| Pila Pharma AB (publ) | -8.81 Million SEK | 182.451% |
| Ascelia Pharma AB (publ) | -108.55 Million SEK | 106.693% |
| Diagonal Bio AB (publ) | -11.46 Million SEK | 163.353% |